Products
Calendar
Audience
Events
Contact
Related reading
Pharma leaders meet with PM Takaichi in push for Japan to retain R&D edge
With China's growing dominance in the biopharma R&D sector, a collection of g | A group of over 20 global pharma leaders met with…
How lab data powers precision commercialization to drive therapy adoption
Drug commercialization depends on reaching the right physicians at the right moment. | Drug commercialization depends on reaching…
Fierce Pharma Asia—Takeda’s historic narcolepsy nod; Daiichi’s accounting…
Takeda's first-in-class orexin treatment won an FDA nod in narcolepsy. Daiichi Sankyo faced investor pushback after admitting to…
FDA, UK drug regulator deepen transatlantic ties with new liaison program
The United Kingdom's Medicines and Healthcare products Regulatory Agency (MHRA) and the U.S. | The program looks to support…
Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Launch ADME-One™: a…
Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Launch ADME-One™: a High-Throughput ADME Platform That Brings…
MrBeast, Snapchat, AI and more: Pharma marketing’s pulse check
As Fierce Pharma Week approaches, the Fierce Pharma Marketing team is taking stock of some of the biggest trends reshaping how…
